-
Professor Xiaojie Bian: Advances and Future Directions in the Treatment of Advanced Prostate Cancer in the Era of Precision Stratification
In recent years, the treatment paradigm for advanced prostate cancer has undergone a profound transformation, shifting from conventional empiric treatment toward precision stratification. With the increasing availability of genetic testing and the emergence of novel targeted therapies, individualized treatment based on molecular characteristics has become an important direction in clinical practice. Oncology Frontier · UroStream…
-
Professor Liangyou Gu: From Evidence-Based Breakthroughs to Precision Stratification — Exploring New Pathways for Adjuvant Therapy After Kidney Cancer Surgery
For patients with kidney cancer who undergo radical surgery, reducing the risk of postoperative recurrence, prolonging disease-free survival, and ultimately improving overall survival have long remained key clinical priorities. In recent years, postoperative adjuvant therapy for kidney cancer has evolved from investigations of targeted therapies to breakthroughs with immunotherapy and, more recently, combinations of immunotherapy…
-
Professor Shaogang Wang: Technological Innovation Enabling Precision Minimally Invasive Surgery, with Clinical Research Driving the Future of Urology
In recent years, urology has entered an important period of rapid technological iteration and continuous evolution in treatment concepts. From the accelerated development of advanced domestically manufactured medical equipment to the growing integration of robotic-assisted surgery, molecular imaging, and artificial intelligence into clinical practice, urology is moving toward increasingly minimally invasive, precise, and function-preserving approaches.…
-
Pujiang Prostate Cancer Academic Conference丨Professor Xiao Lin Lu: In-Depth Interpretation of 2026 ASCO GU — Diverse Innovative Therapies Reshape the Treatment Landscape of Advanced Prostate Cancer
The Pujiang Prostate Cancer Academic Conference was held in Shanghai on June 26–27, 2026. In recent years, the development of multiple innovative therapeutic approaches—including radioligand therapy, antibody-drug conjugates (ADCs), bispecific antibodies, and PARP inhibitors—has accelerated rapidly. A series of clinical studies has opened new treatment pathways for patients with metastatic castration-resistant prostate cancer (mCRPC) and…
-
Prof. Liang Huang: From “One-Size-Fits-All” to “Tailored Treatment” — De-escalation and Advancement in Individualized Surgical Management of Breast Cancer | 2026 Lingnan Breast Cancer Academic Forum
Breast cancer surgery is undergoing a profound transformation, shifting from “maximum tolerable surgery” toward “minimum effective treatment.” How to precisely “do less” while maintaining oncologic efficacy, and how to redefine the role of surgery throughout the disease course, have become major topics of clinical discussion. Recently, at the 2026 Lingnan Breast Cancer Academic Forum, Oncology…
-
23rd World Breast Health Congress丨Prof. Jin Zhang: China’s Breast Cancer Care Has Transitioned from Following to Leading, with Whole-Life-Cycle Management Experience Benefiting the World
Breast cancer is a malignancy that poses a serious threat to women’s health worldwide. Establishing a whole-life-cycle management system covering prevention, screening, diagnosis, treatment, and rehabilitation has become a key consensus and development direction in the global breast health community. Recently, the 23rd World Breast Health Congress was held in Tianjin from May 8 to…
-
23rd World Breast Health Congress丨Prof. Jian Yin: Building on Local Practice to Advance the Standardization and Internationalization of Oncoplastic Breast Surgery
Breast cancer is one of the most common malignancies affecting women worldwide. With the widespread adoption of early screening and diagnosis and continued advances in comprehensive treatment, survival rates among patients with breast cancer have improved significantly. As a result, the need for postoperative quality of life and physical and psychological rehabilitation has become increasingly…
-
23rd World Breast Health Congress丨Prof. Ying Wang: Deepening International Collaboration to Promote Equitable Development of Breast Health in China
Breast cancer has become the most commonly diagnosed malignancy among women worldwide. In recent years, China has continued to explore new approaches to breast cancer screening, clinical diagnosis and treatment, rehabilitation management, and public health education, accumulating extensive experience and steadily improving its overall prevention and treatment capabilities. Recently, the 23rd World Breast Health Congress…
Connecting Medical Expertise through Media